Abstract Details

Title Safety of OnabotulinumtoxinA Treatment With Concomitant Antithrombotic Therapy in Patients With Post-stroke Spasticity: A Pooled Analysis of Randomized, Double-Blind Studies

Topic Movement Disorders

Presentation(s) S56 - (-)

Poster/Presentation
Number 008

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Rozalina Dimitrova, MD, MPH (Allergan, Inc) PRESENTER	No disclosure on file
Lynn M. James (Allergan Plc)	Ms. James has received personal compensation for serving as an employee of AbbVie. Ms. James has stock in AbbVie.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Mitchell F. Brin, MD, FAAN (Abbvie / UC Irvine)	Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.